136 related articles for article (PubMed ID: 23592529)
1. Collagen-like cell-penetrating peptides.
Yamazaki CM; Nakase I; Endo H; Kishimoto S; Mashiyama Y; Masuda R; Futaki S; Koide T
Angew Chem Int Ed Engl; 2013 May; 52(21):5497-500. PubMed ID: 23592529
[No Abstract] [Full Text] [Related]
2. Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes.
Hansen MB; van Gaal E; Minten I; Storm G; van Hest JC; Löwik DW
J Control Release; 2012 Nov; 164(1):87-94. PubMed ID: 23085152
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides: design, synthesis, and applications.
Copolovici DM; Langel K; Eriste E; Langel Ü
ACS Nano; 2014 Mar; 8(3):1972-94. PubMed ID: 24559246
[TBL] [Abstract][Full Text] [Related]
4. Superior cell penetration by a rigid and anisotropic synthetic protein.
Nakayama N; Hagiwara K; Ito Y; Ijiro K; Osada Y; Sano K
Langmuir; 2015 Mar; 31(9):2826-32. PubMed ID: 25710086
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
Guterstam P; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
[TBL] [Abstract][Full Text] [Related]
6. Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells.
Rádis-Baptista G; de la Torre BG; Andreu D
Chem Biol Drug Des; 2012 Jun; 79(6):907-15. PubMed ID: 22405142
[TBL] [Abstract][Full Text] [Related]
7. Cell-penetrable lysine dendrimers for anti-cancer drug delivery: synthesis and preliminary biological evaluation.
Zhao J; Zhou R; Fu X; Ren W; Ma L; Li R; Zhao Y; Guo L
Arch Pharm (Weinheim); 2014 Jul; 347(7):469-77. PubMed ID: 24740712
[TBL] [Abstract][Full Text] [Related]
8. Classes and prediction of cell-penetrating peptides.
Lindgren M; Langel U
Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
[TBL] [Abstract][Full Text] [Related]
9. Cell penetrating peptide (CPP)-conjugated desferrioxamine for enhanced neuroprotection: synthesis and in vitro evaluation.
Goswami D; Machini MT; Silvestre DM; Nomura CS; Esposito BP
Bioconjug Chem; 2014 Nov; 25(11):2067-80. PubMed ID: 25299707
[TBL] [Abstract][Full Text] [Related]
10. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
Verdurmen WP; Thanos M; Ruttekolk IR; Gulbins E; Brock R
J Control Release; 2010 Oct; 147(2):171-9. PubMed ID: 20620184
[TBL] [Abstract][Full Text] [Related]
11. Structural parameters modulating the cellular uptake of disulfide-rich cyclic cell-penetrating peptides: MCoTI-II and SFTI-1.
D'Souza C; Henriques ST; Wang CK; Craik DJ
Eur J Med Chem; 2014 Dec; 88():10-8. PubMed ID: 24985034
[TBL] [Abstract][Full Text] [Related]
12. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
Fang B; Jiang L; Zhang M; Ren FZ
Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
[TBL] [Abstract][Full Text] [Related]
14. Activation of cell-penetrating peptides by disulfide bridge formation of truncated precursors.
Bode SA; Wallbrecher R; Brock R; van Hest JC; Löwik DW
Chem Commun (Camb); 2014 Jan; 50(4):415-7. PubMed ID: 24247922
[TBL] [Abstract][Full Text] [Related]
15. Industrial-scale manufacturing of a possible oligonucleotide cargo CPP-based drug.
Tedebark U; Scozzari A; Werbitzky O; Capaldi D; Holmberg L
Methods Mol Biol; 2011; 683():505-24. PubMed ID: 21053153
[TBL] [Abstract][Full Text] [Related]
16. MAP-mediated nuclear delivery of a cargo protein.
Kenien R; Zaro JL; Shen WC
J Drug Target; 2012 May; 20(4):329-37. PubMed ID: 22225540
[TBL] [Abstract][Full Text] [Related]
17. Blending of diblock and triblock copolypeptide amphiphiles yields cell penetrating vesicles with low toxicity.
Rodriguez AR; Choe UJ; Kamei DT; Deming TJ
Macromol Biosci; 2015 Jan; 15(1):90-7. PubMed ID: 25323924
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides containing 2,5-diketopiperazine (DKP) scaffolds as shuttles for anti-cancer drugs: conformational studies and biological activity.
Feni L; Jütten L; Parente S; Piarulli U; Neundorf I; Diaz D
Chem Commun (Camb); 2020 May; 56(42):5685-5688. PubMed ID: 32319458
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold.
Wallbrecher R; Depré L; Verdurmen WP; Bovée-Geurts PH; van Duinkerken RH; Zekveld MJ; Timmerman P; Brock R
Bioconjug Chem; 2014 May; 25(5):955-64. PubMed ID: 24697151
[TBL] [Abstract][Full Text] [Related]
20. Development of 2-aminoisobutyric acid (Aib)-rich cell-penetrating foldamers for efficient siRNA delivery.
Misawa T; Ohoka N; Oba M; Yamashita H; Tanaka M; Naito M; Demizu Y
Chem Commun (Camb); 2019 Jul; 55(54):7792-7795. PubMed ID: 31210205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
